Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.

TimesSquare Capital U.S. Mid Cap Growth Strategy featured stocks like Cencora, Inc. (NYSE:COR) in the Q4 2023 investor letter.Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (NYSE:COR ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

TimesSquare Capital Management U.S. Focus Growth Strategy highlighted stocks like Cencora, Inc. (NYSE:COR), in the second quarter 2024 investor letter.Cencora, Inc. (NYSE:COR) sources and ...

Cencora Inc (COR) reports a 13% revenue increase and raises full-year guidance, driven by robust US healthcare solutions and strategic market positioning.

Cencora Inc. (NYSE:COR), a leading player in the U.S. Healthcare Technology & Distribution sector, has been drawing significant attention from analysts due to its robust performance and strategic ...

According to the press release announcing the change, the name Cencora is inspired by AmerisourceBergen customers and more than 44,000 employees around the world.

Cencora ( (COR)) just unveiled an update. Cencora, Inc. reported significant growth in its fiscal 2024 results, boasting a 14.7% increase in fourth-quarter revenue to $79.1 billion and a 12.1% ...

Cencora, Inc. (NYSE:COR) Q4 2023 Results Conference Call November 2, 2023 8:30 AM ETCompany ParticipantsBennett Murphy - SVP, Head IR and TreasurySteve ...

Drug distributor Cencora has entered into a definitive agreement to acquire Retina ... "We are pleased to enter our next phase of growth with the support of a leading global pharmaceutical solutions ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #3 ...